Ipamorelin , 98% , 170851-70-4

Synonym(s):
2-Methylalanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-D-phenylalanyl-L-lysinamide acetate;Aib-His-D-2-Nal-D-Phe-Lys-NH2 acetate;NNC 26-0161 acetate

CAS NO.：170851-70-4

Empirical Formula: C38H49N9O5

Molecular Weight: 711.85

MDL number:

PRODUCT Properties

• Melting point: 144-147°C
• Boiling point: 1185.5±65.0 °C(Predicted)
• Density: 1.263±0.06 g/cm3(Predicted)
• storage temp.: -20°C Freezer
• solubility: Acetonitrile (Slightly, Heated), Methanol (Very Slightly), Water (Slightly)
• pka: 13.04±0.46(Predicted)
• form: Solid
• color: White to Off-White
• InChIKey: NEHWBYHLYZGBNO-BVEPWEIPSA-N
• SMILES: C(N)(=O)[C@H](CCCCN)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=C2C(=C1)C=CC=C2)NC(=O)[C@H](CC1N=CNC=1)NC(=O)[C@](C)(C)N

Description and Uses

Ipamorelin (INN) (developmental code name NNC 26-0161) is a peptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS) and a growth hormone secretagogue.It is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 that was derived from GHRP-1.

Ipamorelin is a metabolite of growth hormone releasing peptides (GHRPs). Ipamorelin is a pentapeptide with strong growth hormone releasing potency that evokes insulin release from pancrease of normal and diabetic rats.